进食障碍症状发病年龄与严重程度的遗传景观
结果显示症状中位发病年龄为16-20岁,男性成年发病比例更高;女性行为症状和低体重遗传力较高(SNP-h2=0.31-0.78),而发病年龄和认知症状遗传力较低,多基因评分分析揭示不同通路。
要点
- 进食障碍行为症状中位发病年龄为16-20岁,成年发病与青春期一样常见。
- 男性成年发病比例更高,提示需加强成人服务特别是男性服务。
- 女性行为症状和低体重SNP遗传力为0.31-0.78,发病年龄和认知症状遗传力较低。
核心结论
- 进食障碍症状在成年期发病与青春期一样频繁,挑战刻板印象并强调成人服务投入需求,尤其对男性。
- 行为症状和低体重遗传力强,但发病年龄和认知症状遗传贡献有限。
- 症状水平多基因评分分析揭示不同的生物学和发育通路。
研究设计与样本
- 症状使用ED100K问卷评估。
- SNP遗传力使用GCTA-GREML估计,并与26个多基因评分(PGS,使用SBayesRC计算)进行关联分析。
主要发现
- 症状中位发病年龄范围为16至20岁:呕吐16岁,禁食和过度运动17岁,暴食18岁,泻药19岁,利尿剂20岁,低体重20岁。
- 男性成年发病比例更高。
- 女性行为症状和低体重SNP遗传力为0.31-0.78,发病年龄和认知症状遗传力较低。
- 女性中,较高儿童期肥胖PGS与较早暴食发病相关(约7个月),较高教育程度PGS与较早低体重发病相关(约6个月)。
关键数值与推荐
- 症状中位发病年龄:呕吐16岁,禁食和过度运动17岁,暴食18岁,泻药19岁,利尿剂20岁,低体重20岁。
- 女性行为症状和低体重SNP遗传力(h2)范围为0.31-0.78。
- 女性中儿童期肥胖PGS较高与暴食发病早约7个月相关,教育程度PGS较高与低体重发病早约6个月相关。
临床怎么用
- 临床应关注成年发病的进食障碍,尤其男性,不应仅局限于青少年。
- 遗传评估可考虑行为症状和低体重的遗传力,但发病年龄和认知症状遗传贡献有限。
- 症状水平PGS分析提示不同生物学通路,未来可能指导个体化干预。
局限性
- 需要更大样本量和更准确表型分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Eating disorder treatment is most successful when delivered at first onset, underscoring the importance of early intervention. Genetic factors may contribute to earlier onset, but molecular genetic research into symptom onset and severity remains limited. AIMS: We investigated: (a) age at onset of behavioural symptoms and low weight, including sex and gender differences; and (b) the single-nucleotide polymorphism (SNP)-based heritability and cross-trait polygenic associations of symptoms, onset, and severity. METHOD: Participants (n = 24 973) of genetically derived European ancestry were from the National Institute for Health and Care Research BioResource, including the Genetic Links to Anxiety and Depression Study, the Eating Disorders Genetics Initiative UK and the COVID-19 Psychiatry and Neurological Genetics study. Symptoms were assessed with the ED100K questionnaire. We described sex-stratified onset of binge eating, low weight, self-induced vomiting, laxatives, diuretics, excessive exercise, and fasting. SNP-based heritability was estimated with genome-wide complex trait analysis using genomic-relatedness-based restricted maximum-likelihood. We tested associations with 26 polygenic scores (PGS), which were calculated using SBayesRC. RESULTS: Symptom median onset ranged from 16 to 20 years: vomiting (16 years), fasting and excessive exercise (17 years), binge eating (18 years), laxatives (19 years), diuretics (20 years) and low weight (20 years). Males were disproportionately likely to report adult onset. In females, behavioural symptoms and low weight showed substantial heritability (SNP-based h2 = 0.31-0.78), but age at onset and cognitive symptoms were less heritable. PGS analyses identified distinct pathways: in females, higher childhood obesity PGS was linked to earlier binge eating onset (approximately 7 months), and higher educational attainment PGS to earlier low weight onset (approximately 6 months). CONCLUSIONS: Eating disorder symptoms begin in adulthood as frequently as adolescence, challenging stereotypes and underscoring investment needed in adult services, particularly for males. Although behavioural symptoms and low weight were strongly heritable, age at onset and cognitive symptoms showed limited genetic contribution. Symptom-level PGS analyses highlight distinct biological and developmental pathways. Larger sample sizes and more accurate phenotyping are needed.
引用
- Davies HL, R Ter Kuile A, Ahmad ZU, et al. Mapping the genetic landscape of the age at onset and severity of eating disorder symptoms. Br J Psychiatry. 2026. PMID: 42841245. doi:10.1192/bjp.2026.10763
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。